People have until Sept 13 to submit comments to the FDA about legalizing canabidiol (CBD) – which has documented effectiveness in numerous forms of cancer: https://www.regulations.gov/comment?D=FDA-2017-N-4515-0001
This is the moment to tell the FDA what you think of cannabidiol (CBD) before it is labelled a scheduled drug and restricted internationally.
By Carey Wedler:
On Monday, the FDA invited the public to submit comments on the potential benefits of cannabidiol (CBD), along with a handful of other substances.
Published in the federal register, the announcement explained that the FDA is “requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 drug substances.” The agency will eventually submit a report including this public input to the World Health Organization, which will use the information to make decisions regarding legal access to the substances. The FDA will collaborate with the Department of Health and Human Services (HHS) to produce the report.
Related: Half Of CBD UsersQuit Prescribed Drugs…
View original post 986 more words